Financials
- Market Capitalization 2.48 B
- Employee 890
- Founded 1996
- CEO Matthew M. Mannelly
- Website www.prestigebrands.com
- Headquarter New York, United States
- FIGI BBG000QM0RZ4
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
15.16
ratio cours/chiffre d'affaires
2.79
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1795 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.50 USD | -0.36% | +3.77% | -4.51% | -60.46% | 2.72 B USD | ||
| 1841 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 43.73 USD | -1.04% | -4.62% | -5.55% | -19.02% | 2.54 B USD | ||
| 1888 | BHC Bausch Health Companies Inc. Common Stock | 6.32 USD | +0.32% | -2.32% | +26.91% | -14.01% | 2.36 B USD | ||
| 1955 | HCM HUTCHMED (China) Limited - American Depositary Shares | 12.38 USD | -0.32% | -1.59% | +11.53% | -17.96% | 2.16 B USD |